# Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
Canonical URL: https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-permanent-j-code-for-zevaskynr-prademagene-zamikeracel
Ticker: ABEO
Company: Abeona Therapeutics
Source: Abeona Therapeutics
Published: 2025-10-30 14:45 EST
Original Source URL: https://investors.abeonatherapeutics.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-21 11:30 EST — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043) — Source: Abeona Therapeutics
- 2026-07-01 11:30 EST — [Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ABEO/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-68d0b897) — Source: Abeona Therapeutics
- 2026-06-01 12:30 EST — [Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ABEO/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-9fbfa1ec) — Source: Abeona Therapeutics
- 2026-05-26 12:30 EST — [Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences](https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-participation-in-upcoming-investor-conferences) — Source: Abeona Therapeutics
- 2026-05-13 11:30 EST — [Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update](https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-reports-first-quarter-2026-results-and-provides-pipeline-update) — Source: Abeona Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)